Is Molina Healthcare (MOH) Undervalued After Its Recent Rally?

Molina Healthcare (MOH) has drawn fresh attention after recent performance data showed a 1 day decline of 2.3% alongside a year to date gain of 13.3%. This has prompted investors to reassess the health insurer’s valuation.

Short term trading has been choppy for Molina Healthcare, with a 7 day share price return of 4.2% and a 1 day decline coinciding with the latest move to US$202.22. However, the year to date share price return of 13.3% and 1 year total shareholder return of 14.7% point to momentum that still leans positive. At the same time, the 3 and 5 year total shareholder returns show sizeable declines that keep longer term investors focused on whether the recent strength reflects improving growth expectations or simply a reassessment of risk.

Scan how Molina Healthcare fits into a broader opportunity set by comparing it with a hand picked group of 11 resilient stocks with low risk scores that aim to pair resilience with steadier returns.

Molina Healthcare has rallied over the past year and still trades just below analyst targets and at a large estimated discount to intrinsic value. Is most of the upside already used up, or is the market still catching up?

Most Popular Narrative: 3% Undervalued

Molina Healthcare’s most followed valuation narrative places fair value at about $209.12, a touch above the last close of $202.22. This frames the stock as modestly undervalued rather than deeply mispriced.

Molina's successful track record of winning RFPs, including new contracts in Nevada and Illinois, is expected to drive significant revenue growth, with projected incremental annual premium revenue of approximately $800 million. This should positively impact revenue and EPS growth.

See why 63 investors see Molina Healthcare as 3% undervalued.

Result: Fair Value of $209.12 (UNDERVALUED)

Still, the Molina Healthcare story can be knocked off course if Medicaid funding is cut or if Marketplace rules and subsidies shift in ways that reduce earnings visibility.

Find out about the key risks to this Molina Healthcare narrative.

Next Steps

Sentiment around Molina Healthcare in this article may lean optimistic, so move quickly to review the numbers yourself and stress test your thesis against 3 key rewards.

Looking for more investment ideas beyond Molina Healthcare?

If Molina Healthcare has sharpened your thinking, do not stop there. Broaden your watchlist with a few focused stock ideas filtered for different goals and risk levels.

• Target potential mispricing by scanning a curated pool of quality companies trading below estimates of fair value through the 33 high quality undervalued stocks.
• Strengthen your foundation by checking a list of solid balance sheet and fundamentals (22 results) that highlights businesses with sturdier finances and healthier fundamentals.
• Stay early to emerging opportunities by reviewing a focused 16 high quality undiscovered gems that many investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com